Your browser doesn't support javascript.
loading
Sequencing paired tumor DNA and white blood cells improves circulating tumor DNA tracking and detects pathogenic germline variants in localized colon cancer.
Gimeno-Valiente, F; Martín-Arana, J; Tébar-Martínez, R; Gambardella, V; Martínez-Ciarpaglini, C; García-Micó, B; Martínez-Castedo, B; Palomar, B; García-Bartolomé, M; Seguí, V; Huerta, M; Moro-Valdezate, D; Pla-Martí, V; Pérez-Santiago, L; Roselló, S; Roda, D; Cervantes, A; Tarazona, N.
Affiliation
  • Gimeno-Valiente F; Cancer Evolution and Genome Instability Laboratory, University College London Cancer Institute, London, UK.
  • Martín-Arana J; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid.
  • Tébar-Martínez R; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia.
  • Gambardella V; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia.
  • Martínez-Ciarpaglini C; CIBERONC, Instituto de Salud Carlos III, Madrid; Department of Pathology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia.
  • García-Micó B; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid.
  • Martínez-Castedo B; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid.
  • Palomar B; Department of Pathology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia.
  • García-Bartolomé M; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia.
  • Seguí V; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia.
  • Huerta M; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia.
  • Moro-Valdezate D; Colorectal Surgery Unit, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, Department of Surgery, University of Valencia, Valencia, Spain.
  • Pla-Martí V; Colorectal Surgery Unit, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, Department of Surgery, University of Valencia, Valencia, Spain.
  • Pérez-Santiago L; Colorectal Surgery Unit, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, Department of Surgery, University of Valencia, Valencia, Spain.
  • Roselló S; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid.
  • Roda D; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid.
  • Cervantes A; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid. Electronic address: andres.cervantes@uv.es.
  • Tarazona N; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid. Electronic address: noetalla@incliva.es.
ESMO Open ; 8(6): 102051, 2023 Dec.
Article de En | MEDLINE | ID: mdl-37951129

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du côlon / ADN tumoral circulant Limites: Humans Langue: En Journal: ESMO Open Année: 2023 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du côlon / ADN tumoral circulant Limites: Humans Langue: En Journal: ESMO Open Année: 2023 Type de document: Article Pays d'affiliation: Royaume-Uni